Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
9
2019
CMS Finalizes Rule Requiring Disclosure of Drug Prices in TV Ads Mintz
Oct
30
2013
Financing Trends in Life Sciences Companies [VIDEO] Mintz
Jun
3
2013
Tesoro to Pay $1.1 Million to Resolve Clean Air Act Violations U.S. Environmental Protection Agency
Jan
18
2021
340B Administrative Dispute Resolution Goes Live Amid a Flurry of 340B Litigation Mintz
Jul
31
2018
Are Your Food Products in Compliance With the New Prop 65 Requirements? Polsinelli PC
Apr
1
2016
Biosimilar Developments Continue at a Rapid Pace Mintz
Oct
3
2018
Cannabis Advertising Womble Bond Dickinson (US) LLP
Apr
27
2020
CMS Releases 340B Drug Acquisition Cost Survey, Responses Due May 15, 2020 McDermott Will & Emery
Apr
8
2019
Congress Keeping its Focus on Drug Costs Mintz
Aug
14
2019
Congress Looking to Streamline CBD Drug Research Mintz
Nov
12
2020
COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA Requirements [PODCAST] K&L Gates
Jun
25
2013
Energy Disclosures for Non-Residential Buildings Greenberg Traurig, LLP
Jan
11
2014
Energy Reform Approved by the Mexican Congress Greenberg Traurig, LLP
Feb
28
2020
False Claims Act Whistleblower Recovers More than $2.5M in Damages in False Claims Act Whistleblower Retaliation Case Zuckerman Law
Jan
8
2019
FDA 2018 Year in Review: Medical Devices McDermott Will & Emery
Oct
10
2018
FDA Adds Eight New Substances to its Inventory of Effective FCS Notifications - October 2018 Keller and Heckman LLP
Jun
8
2017
FDA Adds Three New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
Jan
12
2015
FDA Issues Draft Guidance on Transfer of a 510(k) Clearance Barnes & Thornburg LLP
Mar
24
2020
FDA Offers Guidance on Clinical Trials During COVID-19 Pandemic McDermott Will & Emery
May
5
2017
FDA Removes Clearance for Potassium Perchlorate in Sealing Gaskets Based on Abandonment Keller and Heckman LLP
Apr
20
2021
FDA Reverses 11th Hour HHS Action to Exempt Certain Devices from 510(k) Premarket Requirement Mintz
Apr
1
2019
FDA Silent on CBD Regulation at Cosmetics Conference, But Legislation May Be Imminent Mintz
Jan
26
2024
FDA Takes First Step Toward International Regulation of Gene Therapies to Treat Rare Diseases Greenberg Traurig, LLP
Jun
23
2013
Federal Trade Commission (FTC) v. Actavis: What Does It Mean for Reverse-Payment Settlements? Sheppard, Mullin, Richter & Hampton LLP
Nov
26
2019
Ferrero successfully enforces the Tic Tac shape mark in Italy K&L Gates
Jul
14
2022
Finding a Bank and Insurance Company for a Cannabis Business Bradley Arant Boult Cummings LLP
Feb
13
2020
First Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Jan
31
2020
Food Contact Materials: What Are Your Legal Responsibilities? Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins